ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
In a move to expand its human health and functional food businesses, the Danish biotechnology firm Novozymes will pay $150 million for a majority stake in India’s Synergia Life Sciences, which makes probiotics and vitamin K2-7. Novozymes expects Synergia to contribute about $23 million in annual sales. In 2020, Novozymes announced deals for the probiotics companies PrecisionBiotics and Microbiome Labs.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter